Labcorp HoldingsLTS:0JSY +1.14%81 PB Ratio is 2.54 as of Jun. 28, 2026, which is 17% above its 10-year median of 2.17. GuruFocus rates LTS:0JSY with a GF Score™ of 81/100 and a GF Value™ of $269.87 (Fairly Valued). The stock has 6 warning signs investors should review. Among 196 Medical Diagnostics & Research companies, Labcorp Holdings ranks worse than 61.22% on this metric.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2026-06-28), Labcorp Holdings's share price is $269.884. Labcorp Holdings's Book Value per Share for the quarter that ended in Mar. 2026 was $106.06. Hence, Labcorp Holdings's PB Ratio of today is 2.54.
Warning Sign:
Labcorp Holdings Inc stock PB Ratio (=2.56) is close to 10-year high of 2.76.
The historical rank and industry rank for Labcorp Holdings's PB Ratio or its related term are showing as below:
LTS:0JSY'
s PB Ratio Range Over the Past 10 Years
Min: 1.18 Med: 2.17 Max: 2.76
Current: 2.56
During the past 13 years, Labcorp Holdings's highest PB Ratio was 2.76. The lowest was 1.18. And the median was 2.17.
LTS:0JSY's PB Ratio is ranked worse than 61.22% of 196
companies
in the Medical Diagnostics & Research industry
Industry Median: 2.03
vs LTS:0JSY: 2.56
During the past 12 months, Labcorp Holdings's average Book Value Per Share Growth Rate was 7.00% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was -2.90% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was -0.60% per year.
During the past 10 years, the average Book Value Per Share Growth Rate was 8.10% per year.
During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of Labcorp Holdings was 47.40% per year. The lowest was -28.30% per year. And the median was 11.45% per year.
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
Labcorp Holdings PB Ratio Related Terms
Labcorp Holdings PB Ratio Historical Data
* Premium members only.
The historical data trend for Labcorp Holdings's PB Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Diagnostics & Research subindustry, Labcorp Holdings's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Labcorp Holdings PB Ratio vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Labcorp Holdings's PB Ratio distribution charts can be found below:
* The bar in red indicates where Labcorp Holdings's PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
Labcorp Holdings (LTS:0JSY) has a PB Ratio of 2.54 as of Jun. 28, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Labcorp Holdings and its competitors. This is 17% above median its historical median of 2.17. Over the past decade, Labcorp Holdings' PB Ratio has ranged from 1.18 to 2.76. According to the industry distribution chart, Labcorp Holdings ranks #120 out of 196 companies in the Medical Diagnostics & Research industry, placing it in the top 61.2%.
Is Labcorp Holdings' PB Ratio too high?
Labcorp Holdings' current PB Ratio of 2.54 is 17% above median its 10-year median of 2.17. Over the past 10 years, this metric has ranged from a low of 1.18 to a high of 2.76. The Medical Diagnostics & Research industry median PB Ratio is 2.03. Labcorp Holdings' value of 2.54 is 25.1% above this industry median. Based on the distribution chart, Labcorp Holdings ranks #120 out of 196 companies in the Medical Diagnostics & Research industry, which is below the industry midpoint. Overall, Labcorp Holdings has a GF Score™ of 81/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Labcorp Holdings' PB Ratio compare to DGX and MTD?
According to the Medical Diagnostics & Research industry distribution chart, Labcorp Holdings ranks #120 out of 196 companies for PB Ratio. This places Labcorp Holdings in the lower half of its industry. The industry median PB Ratio is 2.03. Labcorp Holdings' value of 2.54 is 25.1% above this benchmark. Historically, Labcorp Holdings' own PB Ratio has ranged from 1.18 to 2.76 over the past decade. While the company's 10-year median is 2.17 vs. the industry median of 2.03, Labcorp Holdings has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Medical Diagnostics & Research company?
The median PB Ratio among Medical Diagnostics & Research companies is 2.03, based on 196 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Labcorp Holdings's current PB Ratio of 2.54 is 25.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Labcorp Holdings and its competitors. For the Medical Diagnostics & Research industry, the median PB Ratio is 2.03 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Labcorp Holdings's current PB Ratio is 2.54, which is 17% above median its own 10-year median of 2.17. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Labcorp Holdings stock overvalued right now?
Based on GuruFocus' analysis, Labcorp Holdings (LTS:0JSY) is currently considered Fairly Valued. The stock's GF Value™ is $269.87, compared to a current price of $269.88 — trading 0% above its estimated fair value. The current PB Ratio is 2.54, which is 17% above median its 10-year median of 2.17 and 25.1% above the Medical Diagnostics & Research industry median of 2.03. Labcorp Holdings' overall GF Score™ is 81/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For Labcorp Holdings (LTS:0JSY), the current PB Ratio is 2.54 as of Jun. 28, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Labcorp Holdings (LTS:0JSY) Overvalued in 2026?
Based on GuruFocus' analysis, Labcorp Holdings stock appears to be overvalued.
The current stock price of $269.88 is trading 0% above its estimated GF Value™ of $269.87.
GuruFocus considers Labcorp Holdings to be Fairly Valued.
Key valuation signals for LTS:0JSY:
PB Ratio: 2.54 (17% above median its 10-year median of 2.17)
GF Value™: $269.87 vs. price of $269.88 (0% above fair value)
Industry Position: 25.1% above the Medical Diagnostics & Research median (#120 of 196)
No single metric tells the full story. See the LTS:0JSY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Labcorp is one of the nation's two largest independent clinical laboratories, with roughly 20% of the independent lab market. The company operates approximately 2,000 patient-service centers, offering a broad range of 5,000 clinical lab tests, ranging from uncomplicated routine blood and urine screens to complex oncology and genomic testing.
81GF Score
Get the complete analysis for LTS:0JSY
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LTS:0JSY has been successfully added to your 
